Conduent (NASDAQ:CNDT) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS
by Doug Wharley · The Cerbat GemConduent (NASDAQ:CNDT – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01, Briefing.com reports. The company had revenue of $807.00 million during the quarter, compared to analysts’ expectations of $817.33 million. Conduent had a negative return on equity of 7.81% and a net margin of 0.88%. Conduent’s revenue was down 13.4% on a year-over-year basis. During the same period in the prior year, the business posted ($0.09) EPS. Conduent updated its FY 2024 guidance to EPS.
Conduent Trading Up 0.5 %
CNDT stock traded up $0.02 during midday trading on Friday, hitting $4.10. 1,272,626 shares of the company’s stock were exchanged, compared to its average volume of 1,100,433. Conduent has a one year low of $2.40 and a one year high of $4.22. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.65 and a current ratio of 1.65. The company has a market cap of $665.84 million, a PE ratio of 19.52 and a beta of 1.48. The stock’s fifty day moving average price is $3.84 and its 200-day moving average price is $3.64.
Conduent Company Profile
Conduent Incorporated provides digital business solutions and services for the commercial, government, and transportation spectrum in the United States, Europe, and internationally. It operates through three segments: Commercial, Government Services, and Transportation. The Commercial segment offers business process services and customized solutions to clients in various industries; and customer experience management, business operations, healthcare claims and administration, and human capital solutions.
Read More
- Five stocks we like better than Conduent
- The How And Why of Investing in Oil Stocks
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- What is the Shanghai Stock Exchange Composite Index?
- MarketBeat Week in Review – 11/4 – 11/8
- 3 Healthcare Dividend Stocks to Buy
- Trump’s Return: Which Sectors Will Benefit Most?